Literature DB >> 18310848

Chondromyxoid fibroma of the seventh cervical vertebra.

Ashish Jonathan1, Vedantam Rajshekhar, Geeta Chacko.   

Abstract

Chondromyxoid fibroma is a rare benign bone tumor representing less than 0.5% of all bone tumors. It commonly involves the long tubular bones. Involvement of the spine is rare. A 35-year-old man presented with history of neck pain, restriction of neck movements, pain and numbness along the medial aspect of the left forearm and weakness with wasting of the left hand. A presumptive diagnosis of a bony tumor such as an aneurysmal bone cyst or a giant cell tumor involving the seventh vertebral body was made on plain X-rays, MRI and bone scan. He underwent C7 central corpectomy, incomplete intralesional curettage with iliac bone grafting and C6 to T1 interspinous wiring. The histological diagnosis was chondromyxoid fibroma. On eight years' follow-up, CT scan showed no progression of the tumor with good alignment and fusion of the graft at the site of the corpectomy. The authors conclude that corpectomy and iliac bone grafting for chondromyxoid fibroma has a good outcome on long-term follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18310848     DOI: 10.4103/0028-3886.39323

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  3 in total

1.  Chondromyxoid fibroma of the skull base invading the occipitocervical junction: report of a unique case and discussion.

Authors:  Matthew Crocker; Robert Corns; Istvan Bodi; Antoine Zrinzo; Michael Gleeson; Nick Thomas
Journal:  Skull Base       Date:  2010-03

2.  Chondromyxoid fibroma of the cervical spine: A case report.

Authors:  Cheng Li; Sen Li; Wei Hu
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Chondromyxoid Fibroma of Two Cervical Vertebrae with Involvement of Surrounding Soft Tissue: Radiologic Diagnostic Dilemma.

Authors:  Shokouh Taghipour Zahir; Naser Sefidrokh Sharahjin; Farzad Sadlu Parizi; Koorosh Rahmani
Journal:  Iran J Radiol       Date:  2015-09-29       Impact factor: 0.212

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.